Exercise and Oscillatory Positive Expiratory Pressure Therapy in Cystic Fibrosis
Launched by UNIVERSITY OF ZURICH · Apr 20, 2016
Trial Information
Current as of October 30, 2025
Completed
Keywords
ClinConnect Summary
Regular airway clearance is an integral component of cystic fibrosis care and of critical importance to lung health. Exercise and standardized chest physiotherapy are accepted airway clearance techniques in cystic fibrosis. Different airway clearance techniques are available, but there is no evidence that one technique or a combination is superior. Oscillatory positive expiratory pressure with the Flutter® is a widely used airway clearance technique in the European countries and has been shown to favourably alter sputum viscoelasticity in cystic fibrosis.
This randomized crossover study is...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed diagnosis of CF based on either two CF-causing mutations and/or a sweat chloride concentration during two tests of \> 60 mmol/l
- • Patients that are able to provide sputum samples
- • Adult age ≥ 18 years
- Exclusion Criteria:
- • Unstable condition affecting participation in the exercise experiments (i.e., major hemoptysis or pneumothorax within the last 3 months, acute exacerbation and iv-antibiotics during the last 4 weeks, unstable allergic bronchopulmonary aspergillosis, listed for lung transplantation, major musculoskeletal injuries such as fractures or sprains during the last 2 months, others according to the impression of the doctor)
- • Cardiac arrhythmias with exercise
- • Requiring additional oxygen with exercise
- • Colonization with Burkholderia cenocepacia
- • Status post lung transplantation
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, Switzerland
Zurich, Switzerland
Zurich, Switzerland
Patients applied
Trial Officials
Thomas Radtke, PhD
Principal Investigator
University of Zurich
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials